vs
Side-by-side financial comparison of iRhythm Holdings, Inc. (IRTC) and STRATASYS LTD. (SSYS). Click either name above to swap in a different company.
iRhythm Holdings, Inc. is the larger business by last-quarter revenue ($208.9M vs $137.0M, roughly 1.5× STRATASYS LTD.). iRhythm Holdings, Inc. runs the higher net margin — 2.7% vs -40.6%, a 43.3% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs -2.2%). iRhythm Holdings, Inc. produced more free cash flow last quarter ($14.5M vs $2.5M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs -7.4%).
iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.
Stratasys, Ltd. is an American-Israeli manufacturer of 3D printers, software, and materials for polymer additive manufacturing as well as 3D-printed parts on-demand. The company is incorporated in Israel. Engineers use Stratasys systems to model complex geometries in a wide range of polymer materials, including: ABS, polyphenylsulfone (PPSF), polycarbonate (PC), polyetherimide and Nylon 12.
IRTC vs SSYS — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $208.9M | $137.0M |
| Net Profit | $5.6M | $-55.6M |
| Gross Margin | 70.9% | 41.0% |
| Operating Margin | 1.1% | -16.6% |
| Net Margin | 2.7% | -40.6% |
| Revenue YoY | 27.1% | -2.2% |
| Net Profit YoY | 518.5% | -109.0% |
| EPS (diluted) | $0.18 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $208.9M | — | ||
| Q3 25 | $192.9M | $137.0M | ||
| Q2 25 | $186.7M | $138.1M | ||
| Q1 25 | $158.7M | $136.0M | ||
| Q4 24 | $164.3M | — | ||
| Q3 24 | $147.5M | $140.0M | ||
| Q2 24 | $148.0M | $138.0M | ||
| Q1 24 | $131.9M | $144.1M |
| Q4 25 | $5.6M | — | ||
| Q3 25 | $-5.2M | $-55.6M | ||
| Q2 25 | $-14.2M | $-16.7M | ||
| Q1 25 | $-30.7M | $-13.1M | ||
| Q4 24 | $-1.3M | — | ||
| Q3 24 | $-46.2M | $-26.6M | ||
| Q2 24 | $-20.1M | $-25.7M | ||
| Q1 24 | $-45.7M | $-26.0M |
| Q4 25 | 70.9% | — | ||
| Q3 25 | 71.1% | 41.0% | ||
| Q2 25 | 71.2% | 43.1% | ||
| Q1 25 | 68.8% | 44.3% | ||
| Q4 24 | 70.0% | — | ||
| Q3 24 | 68.8% | 44.8% | ||
| Q2 24 | 69.9% | 43.8% | ||
| Q1 24 | 66.3% | 44.4% |
| Q4 25 | 1.1% | — | ||
| Q3 25 | -4.4% | -16.6% | ||
| Q2 25 | -10.0% | -12.0% | ||
| Q1 25 | -20.5% | -9.1% | ||
| Q4 24 | -2.5% | — | ||
| Q3 24 | -34.1% | -18.2% | ||
| Q2 24 | -15.5% | -18.9% | ||
| Q1 24 | -28.9% | -17.0% |
| Q4 25 | 2.7% | — | ||
| Q3 25 | -2.7% | -40.6% | ||
| Q2 25 | -7.6% | -12.1% | ||
| Q1 25 | -19.3% | -9.6% | ||
| Q4 24 | -0.8% | — | ||
| Q3 24 | -31.3% | -19.0% | ||
| Q2 24 | -13.6% | -18.6% | ||
| Q1 24 | -34.6% | -18.0% |
| Q4 25 | $0.18 | — | ||
| Q3 25 | $-0.16 | — | ||
| Q2 25 | $-0.44 | — | ||
| Q1 25 | $-0.97 | — | ||
| Q4 24 | $-0.03 | — | ||
| Q3 24 | $-1.48 | — | ||
| Q2 24 | $-0.65 | — | ||
| Q1 24 | $-1.47 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $583.8M | $71.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $152.7M | $852.5M |
| Total Assets | $1.0B | $1.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $583.8M | — | ||
| Q3 25 | $565.2M | $71.5M | ||
| Q2 25 | $545.5M | $71.1M | ||
| Q1 25 | $520.6M | $70.1M | ||
| Q4 24 | $535.6M | — | ||
| Q3 24 | $522.0M | $64.0M | ||
| Q2 24 | $561.5M | $70.9M | ||
| Q1 24 | $569.1M | $91.1M |
| Q4 25 | $152.7M | — | ||
| Q3 25 | $121.9M | $852.5M | ||
| Q2 25 | $103.7M | $902.4M | ||
| Q1 25 | $86.7M | $784.8M | ||
| Q4 24 | $90.9M | — | ||
| Q3 24 | $71.8M | $831.8M | ||
| Q2 24 | $99.2M | $850.5M | ||
| Q1 24 | $90.3M | $866.1M |
| Q4 25 | $1.0B | — | ||
| Q3 25 | $995.2M | $1.1B | ||
| Q2 25 | $964.0M | $1.1B | ||
| Q1 25 | $926.1M | $1.0B | ||
| Q4 24 | $931.4M | — | ||
| Q3 24 | $909.7M | $1.1B | ||
| Q2 24 | $919.2M | $1.1B | ||
| Q1 24 | $909.8M | $1.1B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.2M | $6.9M |
| Free Cash FlowOCF − Capex | $14.5M | $2.5M |
| FCF MarginFCF / Revenue | 6.9% | 1.8% |
| Capex IntensityCapex / Revenue | 5.6% | 3.2% |
| Cash ConversionOCF / Net Profit | 4.70× | — |
| TTM Free Cash FlowTrailing 4 quarters | $34.5M | $-11.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.2M | — | ||
| Q3 25 | $34.9M | $6.9M | ||
| Q2 25 | $27.7M | $-1.1M | ||
| Q1 25 | $-7.9M | $4.5M | ||
| Q4 24 | $19.2M | — | ||
| Q3 24 | $24.3M | $-4.5M | ||
| Q2 24 | $11.8M | $-2.4M | ||
| Q1 24 | $-52.0M | $7.3M |
| Q4 25 | $14.5M | — | ||
| Q3 25 | $20.1M | $2.5M | ||
| Q2 25 | $17.3M | $-8.4M | ||
| Q1 25 | $-17.3M | $789.0K | ||
| Q4 24 | $12.4M | — | ||
| Q3 24 | $15.5M | $-6.3M | ||
| Q2 24 | $3.4M | $-4.9M | ||
| Q1 24 | $-61.8M | $5.0M |
| Q4 25 | 6.9% | — | ||
| Q3 25 | 10.4% | 1.8% | ||
| Q2 25 | 9.3% | -6.1% | ||
| Q1 25 | -10.9% | 0.6% | ||
| Q4 24 | 7.5% | — | ||
| Q3 24 | 10.5% | -4.5% | ||
| Q2 24 | 2.3% | -3.6% | ||
| Q1 24 | -46.8% | 3.5% |
| Q4 25 | 5.6% | — | ||
| Q3 25 | 7.7% | 3.2% | ||
| Q2 25 | 5.6% | 5.3% | ||
| Q1 25 | 5.9% | 2.8% | ||
| Q4 24 | 4.2% | — | ||
| Q3 24 | 6.0% | 1.3% | ||
| Q2 24 | 5.7% | 1.8% | ||
| Q1 24 | 7.4% | 1.6% |
| Q4 25 | 4.70× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
SSYS
Segment breakdown not available.
